BioCryst Pharmaceuticals shares owned by Martingale Asset Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Martingale Asset Management
from 13F filings
Historical chart of Martingale Asset Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Martingale Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $334k | 54k | 6.18 |
| 2024-03-31 | $226k | 45k | 5.08 |
| 2023-12-31 | $96k | 16k | 5.99 |
More positions owned by Martingale Asset Management
View all positions for Martingale Asset Management